Michael J. Luzzio, Chairperson
Senior Research Investigator
Novartis Institutes for BioMedical Research, Cambridge, MA
michael.luzzio@novartis.com
Stephen A. Munk, Ph.D. Chairperson-Elect
Chief Executive Officer and President
Ash Stevens Inc., Detroit, MI
samunk@ashstevens.com
Billy W. Day, Ph.D. Past Chairperson
Professor, Dept. of Pharmacy Sciences
University of Pittsburgh School of Pharmacy, Pittsburgh, PA
bday@pitt.edu
Stacie S. Canan, Ph.D. (2012-2014)
Executive Director, Chemistry
Celgene Corporation, San Diego, CA
scanan@celgene.com
Michael P. Dillon, Ph.D. (2012-2014)
Executive Director and Head, Chemical Sciences
Novartis Institutes for BioMedical Research, Emeryville, CA
michael.dillon@novatis.com
John A. Katzenellenbogen, Ph.D. (2013-2015)
Professor, Dept. of Chemistry
University of Illinois at Urbana-Champaign, Urbana, IL
jkatzene@illinois.edu
|
George S. Sheppard, Ph.D. (2013-2015)
Associate Research Fellow
Abbvie
george.s.sheppard@abbvie.com
David E. Uehling, Ph.D. (2012-2014)
Senior Chemist
Ontario Institute for Cancer Research, Toronto, Canada
daviduehling@gmail.com
Gregory D. Vite, Ph.D. (2011-2015)
Executive Director, Oncology Chemistry
Bristol-Myers Squibb Co., Princeton, NJ
gregory.vite@bms.com
Shaomeng Wang, Ph.D. (2013-2015)
Professor of Medicine, Pharmacology and Medicinal Chemistry
University of Michigan Comprehensive Cancer Center
Ann Arbor, MI
shaomeng@umich.edu
Wendy B. Young, Ph.D. (2012-2014)
Associate Director, Discovery Chemistry
Genentech Inc., South San Francisco, CA
young.wendy@gene.com
|